Technology | Magnetic Resonance Imaging (MRI) | January 09, 2017

Siemens Shows Magnetom Sempra MRI Scanner at RSNA 2016

1.5 Tesla MRI system offers applications to improve competitiveness and potentially boost profitability for radiology providers

Siemens Healthineers, Magnetom Sempra, MRI scanner, RSNA 2016

January 9, 2017 — At the 2016 annual meeting of the Radiological Society of North America (RSNA), Siemens Healthineers presented the Magnetom Sempra, a 1.5T magnetic resonance imaging (MRI) scanner with low operating costs, innovative technologies and a unique, integrated Siemens Healthineers service concept. The Magnetom Sempra is designed to allow radiological practices and groups, as well as small and medium-sized hospitals, to work profitably despite growing cost pressures in the industry. Additionally, the system’s standardized workflows are designed to help institutions achieve consistent, user-independent quality.

Achieving consistent MRI results, particularly for follow-up examinations, is extremely important to radiology providers. However, high levels of staff turnover, varying levels of staff experience and diverse patient populations can negatively impact exam quality. With the MRI imaging software DotGO, Magnetom Sempra users can react flexibly to each case and to the condition of each patient while simultaneously standardizing the exam. The system also includes as standard three of the company’s Dot (Day optimizing throughput) engines to automate and streamline workflow when examining the brain, spine and large joints. These Dot engines cover roughly three-quarters of the average examination volume, and help users increase productivity as well as avoid unnecessary repeat scans.

Given healthcare’s competitive pressure and the rise in quality demands, clinical differentiation is increasingly important for radiology providers. The Magnetom Sempra includes applications for responding to these needs. Now, facilities can scan in the presence of MR-safe metallic implants with better visualization of the soft tissue surrounding the implant. Even patients with knee implants can receive high-quality imaging, which was often impossible in the past. The system’s software platform includes Quiet Suite technology, which features optimized gradient switching that can reduce sound pressure by up to 97 percent in brain and musculoskeletal exams with comparable image quality. This technology is particularly beneficial for anxious patients and provides a more positive patient experience during MRI exams. The system can achieve high image quality with short breath-hold times, which means patients with shortness of breath can now be scanned, too.

The system can increase productivity while reducing operating costs. Ten-minute exams with time- and image-optimized protocols cover most commonly scanned body parts. For example, a complete brain scan — from patient positioning on the table to exam completion — is just 10 minutes with the Magnetom Sempra. This exam time may help practices and hospitals operate profitably despite increasing financial pressure due to reduced reimbursement rates. The system’s embedded Siemens Healthineers Connect Plan offers financial certainty and lowers total cost of ownership by delivering remote service, and helps ensure higher uptime.

To reduce overall operating costs, the system is equipped with Eco-Power technology, which monitors and controls the magnet-cooling helium. In stand-by mode, Eco-Power monitors the helium cycle and controls helium cooling and re-liquefaction more efficiently to reduce energy consumption by up to 30 percent compared to the scanner’s normal mode. A supplementary feature, Zero Helium boil-off technology, prevents helium evaporation, so operators can avoid expensive helium refills and resultant downtimes.

The Magnetom Sempra is U.S. Food and Drug Administration (FDA) 510(k) pending.

For more information: www.healthcare.siemens.com

Related Content

ADHD Medication May Affect Brain Development in Children

Images of regions of interest (colored lines) in the white matter skeleton representation. Data from left and right anterior thalamic radiation (ATR) were averaged. Image courtesy of C. Bouziane et al.

News | Neuro Imaging | August 16, 2019
A drug used to treat attention-deficit/hyperactivity disorder (ADHD) appears to affect development of the brain’s...
Profound Medical Receives U.S. FDA 510(k) Clearance for Tulsa-Pro
Technology | Interventional Radiology | August 16, 2019
Profound Medical Corp. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to...
Synaptive Medical Launches Modus Plan With Automated Tractography Segmentation
Technology | Neuro Imaging | August 07, 2019
Synaptive Medical announced the U.S. launch and availability of Modus Plan featuring BrightMatter AutoSeg. This release...
Canon Medical Introduces Encore Orian MR Upgrade Program
News | Magnetic Resonance Imaging (MRI) | August 06, 2019
Canon Medical Systems USA Inc. is helping to provide low-cost patient care solutions for its customers with the launch...
FDA Issues Draft Guidance on Medical Device Safety in MRI Environment
News | Magnetic Resonance Imaging (MRI) | August 01, 2019 | Jeff Zagoudis, Associate Editor
The U.S. Food and Drug Administration (FDA) issued a new draft guidance titled Testing and Labeling Medical Devices for...
Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Feature | Contrast Media | July 18, 2019 | By Greg Freiherr
Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n
AAPM 2019 Features More Than 40 Presentations on ViewRay's MRIdian MRI-guided Radiotherapy
News | Image Guided Radiation Therapy (IGRT) | July 16, 2019
ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the...
FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance...
Insightec's Exablate Neuro Approved With GE Signa Premier MRI in U.S. and Europe
News | Focused Ultrasound Therapy | July 10, 2019
GE Healthcare and Insightec announced U.S. Food and Drug Administration (FDA) approval and CE mark for Insightec’s...
Delta T1 Maps Provide Quantitative, Automated Solution to Assess Brain Tumor Burden
News | Neuro Imaging | July 05, 2019
Imaging Biometrics LLC (IB) a subsidiary of IQ-AI Ltd., is highlighting a recently published study in the American...